


Flamingo Therapeutics Email Formats
Biotechnology Research • Belgium • 11-20 Employees
Flamingo Therapeutics Email Formats
Flamingo Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@flamingotx.com), used 85.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@flamingotx.com | 85.7% |
{first name}.{last name} | john.doe@flamingotx.com | 14.3% |
Key Contact at Flamingo Therapeutics
Morgane Perdomini
Director Of Development At Flamingo Therapeutics
Company overview
| Headquarters | Belgium |
| Website | |
| NAICS | 541714 |
| Employees | 11-20 |
| Socials |
About Flamingo Therapeutics
Flamingo is pioneering RNA-targeted therapies for oncology with state-of-the art chemistries and a clinical-stage pipeline targeting undruggable transcription factors and splice variants. Flamingo Therapeutics has a Phase II trial (PEMDA-HN) evaluating the STAT3 targeting agent danvatirsen, in combination with pembrolizumab, in patients with head and neck squamous cell carcinoma (HNSCC). Flamingo has an alliance with Ionis Pharmaceuticals and is supported by well-known biotechnology investors including Andera Partners, Bpifrance Large Venture, Bpifrance through its FABS and Fonds Biothérapies Innovantes et Maladies Rares funds, Eurazeo - Kurma Partners, Perceptive Advisors, PMV, Pontifax, Sphera, funds managed by Tekla Capital Management LLC and VIB.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Flamingo Therapeutics has 3 employees across 3 departments.
Departments
Number of employees
Flamingo Therapeutics Tech Stack
Discover the technologies and tools that power Flamingo Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Video players
JavaScript libraries
JavaScript libraries
Font scripts
JavaScript libraries
Programming languages
Blogs
UI frameworks
SEO
Hosting
Reverse proxies
Frequently asked questions
4.8
40,000 users



